Canadian Sec - Free Realtime Quote CAD
Bright Minds Biosciences Inc. (DRUG.CN)
46.03
+1.85
+(4.19%)
As of 11:57:32 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in CAD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -0.46 | -0.66 | -1.92 | -4.26 |
| Low Estimate | -0.8 | -1.04 | -3.28 | -8.04 |
| High Estimate | -0.24 | -0.26 | -0.78 | -0.95 |
| Year Ago EPS | -- | -- | -0.94 | -1.92 |
Revenue Estimate
| Currency in CAD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | 0.00% |
Earnings History
| Currency in CAD | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|
| EPS Est. | -- | -0.6 | -0.5 |
| EPS Actual | 0.05 | -0.24 | 0.01 |
| Difference | -- | 0.36 | 0.51 |
| Surprise % | -- | 59.23% | 102.00% |
EPS Trend
| Currency in CAD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.46 | -0.66 | -1.92 | -4.26 |
| 7 Days Ago | -0.46 | -0.68 | -1.96 | -4.35 |
| 30 Days Ago | -0.46 | -0.68 | -1.96 | -4.35 |
| 60 Days Ago | -0.53 | -0.81 | -2.35 | -4.22 |
| 90 Days Ago | -0.37 | -0.47 | -1.7 | -4.03 |
EPS Revisions
| Currency in CAD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | 1 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| DRUG.CN | -- | -- | -104.84% | -122.34% |
| S&P 500 | 13.06% | 3.09% | 8.02% | 13.74% |
Upgrades & Downgrades
| Initiated | Chardan Capital: Buy | 5/7/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/19/2025 |
| Initiated | Piper Sandler: Overweight | 1/23/2025 |
| Initiated | Cantor Fitzgerald: Overweight | 1/10/2025 |
| Initiated | HC Wainwright & Co.: Buy | 1/10/2025 |
| Initiated | Baird: Outperform | 11/25/2024 |
Related Tickers
6XC.F Soleno Therapeutics, Inc.
64.85
+1.25%
688428.SS InnoCare Pharma Limited
20.56
+0.54%
25I.SG ImmuPharma PLC
0.0265
-10.17%
BSFAF BSF Enterprise Plc
0.0584
0.00%
22Z.SG Zealand Pharma A/S
56.18
-6.30%
BT3.BE Lineage Cell Therapeutics Inc
0.4060
+5.73%
328.SG MeiraGTx Holdings PLC
4.7600
-0.83%
688068.SS Beijing Hotgen Biotech Co., Ltd.
109.40
-0.18%
XUPB.F Genfit S.A.
3.7800
-0.53%
SCP.F Scancell Holdings plc
0.0950
0.00%